Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence

(2023) Natia Murvelashvili et al.   Obesity

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study

(2023) Anders Boisen Jensen et al.   OBESITY SURGERY

Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

(2023) Rohit Loomba et al.   Lancet Gastroenterology & Hepatology

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes

(2022) Domenica M. Rubino et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes

(2022) Wahiba Elhag et al.   OBESITY SURGERY

Effect of once‐weekly semaglutide versus thrice‐daily insulin aspart, both as add‐on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes ( SUSTAIN 11): a randomized, open‐label, multinational, phase 3b trial

(2022) Monika Kellerer et al.   DIABETES OBESITY & METABOLISM

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis

(2022) Anne Lautenbach et al.   OBESITY SURGERY

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

(2022) W. Timothy Garvey et al.   NATURE MEDICINE

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality

(2022) Yi Xia et al.   Frontiers in Microbiology

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

(2021) Juan P. Frias et al.   DIABETES CARE

Once-Weekly Semaglutide in Adults with Overweight or Obesity

(2021) John P.H. Wilding et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps—a Scoping Review

(2021) Walid El Ansari et al.   OBESITY SURGERY

Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6

(2021) Michael A. Nauck et al.   Frontiers in Endocrinology

Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study

(2020) Fritz F. Horber et al.   OBESITY SURGERY

Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers

(2020) Stephen A. Harrison et al.   Contemporary Clinical Trials

Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study

(2020) Lena M.S. Carlsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

(2020) Philip N. Newsome et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rising rural body-mass index is the main driver of the global obesity epidemic in adults

(2019)   NATURE

Mechanisms, Pathophysiology, and Management of Obesity

(2017) Steven B. Heymsfield et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus

(2016) Yuya Seko et al.   HEPATOLOGY RESEARCH

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

(2015) Melanie J. Davies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiometabolic Risks and Severity of Obesity in Children and Young Adults

(2015) Asheley C. Skinner et al.   NEW ENGLAND JOURNAL OF MEDICINE